Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Nov 2025 for BIO-TECHNE Corp.
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Alpna Seth: trading record in brief
Alpna Seth has filed trades across 3 companies (mainly through SEC (Form 4)), most often in BIO-TECHNE Corp, Seagen Inc. and Keros Therapeutics, Inc. The record holds 21 filings, for trades running from 26 October 2017 to 30 October 2025.
Every open-market trade on record is a sale: 2 sales worth €1.3M. Other entries cover 16 share grants and 2 option exercises.
The latest filing, published on 3 November 2025, reports a share grant in BIO-TECHNE Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alpna Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,640 shares0Common StockSEC:0000914190-25-000020:0
5,250 shares0Common StockSEC:0001415889-25-015975:0
1,462 shares0Common StockSEC:0001062993-24-018029:0
12,953 shares@ US$229.00100.0% of flowCommon StockSEC:0000950170-23-070868:0
1,625 shares0Common StockSEC:0001062993-23-019858:0
2,044 shares0Common StockSEC:0001203311-23-000060:0
338 shares0Common StockSEC:0001415889-22-010912:0
1,503 shares0Common StockSEC:0000899243-22-018467:0
194 shares0Common StockSEC:0000914190-21-000395:0
1,402 shares0Common StockSEC:0001203311-21-000031:0
10 of 10 declarations
